Pfizer weight loss drug compared to Novo Nordisk’s Ozempic

Weight loss drugs have become a hot topic as health authorities and pharmaceutical companies race to find solutions to the growing global obesity epidemic.

Florian Gaertner | Photo library | Getty Images

An oral drug made pfizer causes the same amount weight loss as well as running faster than the competitor Novo NordiskBlockbuster injection Ozempicaccording to the results of a Phase 2 clinical trial released Monday.

The results were presented at a medical conference late last year. But JAMA network is just now releasing a full peer-reviewed study.

The Pfizer study included 411 adults. type 2 diabetes who has taken the company’s pill, danugliprontwice a day or placebo.

The study showed that patients who took the 120 milligram version of danuglipron lost about 10 pounds over 16 weeks.

This compares to Ozempic’s Phase III clinical trial, which found that adults who took the 1-milligram version of the injection lost about 9.9 pounds in an average of 30 weeks. Patients receive this injection once a week.

The results show that danuglipron can be as effective for weight loss as Ozempic in a shorter period of time.

Pfizer may also have an advantage as an oral treatment option rather than frequent injections.

Both danuglipron and ozempic belong to a class of drugs called glucagon-like peptide-1 antagonists.

They mimic the GLP-1 hormone produced in the gut, which signals the brain when a person is full.

These drugs can also help people manage type 2 diabetes because they stimulate the release of insulin from the pancreas, lowering blood sugar levels.

Pfizer, based in New York, is the latest pharmaceutical company to enter the weight loss market.

Novo Nordisk’s Ozempic and Wegovy have gained a lot of attention in recent years for their weight loss products.miracles.”

Hollywood celebrities, social media influencers and billionaire tech moguls Elon Musk reportedly used popular injections to get rid of unwanted weight.

But experts say drugs could further perpetuate a dangerous diet culture that idealizes weight loss and thinness.

Some patients who stop taking their medications also complain of rebound weight which is difficult to control.

More than 2 out of 5 adults are obese, according to a study. National Institutes of Health. Approximately 1 in 11 adults is severely obese.